Literature DB >> 28809185

A Quality, Benefit, Cost, and Financial Framework for Health Information Technology, E-Prescribing: A Delphi Study.

Paul R DeMuro1, Joan Ash2, Blackford Middleton3, Justin Fletcher4, Cecelia J Madison5.   

Abstract

BACKGROUND: Little research has been conducted about the quality, benefits, costs, and financial considerations associated with health information technology (HIT), particularly informatics technologies, such as e-prescribing, from the perspective of all its stakeholders.
OBJECTIVES: This research effort sought to identify the stakeholders involved in e-prescribing and to identify and rank-order the positives and the negatives from the perspective of the stakeholders to create a framework to assist in the development of incentives and payment mechanisms which result in better managed care.
METHODS: The Delphi method was employed by enlisting a panel of experts. They were presented with the results of initial research in an online survey of questions which sought to prioritize the quality, benefit, cost, and financial effects of e-prescribing from the perspective of each stakeholder. From the results of this study, a framework was presented to framework experts.
RESULTS: The experts added stakeholders and positives and negatives to the initial lists and rank-ordered the positives and negatives of e-prescribing from the perspective of each stakeholder. The aggregate results were summarized by category of stakeholder. The framework experts evaluated the framework.
CONCLUSIONS: Positives and negatives can be rank-ordered from the perspective of each stakeholder. A useful framework was created.

Entities:  

Keywords:  Delphi method; Health information technology; care teams; e-prescribing; frameworks; informatics; managed care; quality; stakeholders

Mesh:

Year:  2017        PMID: 28809185

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  1 in total

1.  Out-of-pocket costs are on the rise for commonly prescribed neurologic medications.

Authors:  Brian C Callaghan; Evan Reynolds; Mousumi Banerjee; Kevin A Kerber; Lesli E Skolarus; Brandon Magliocco; Gregory J Esper; James F Burke
Journal:  Neurology       Date:  2019-05-01       Impact factor: 11.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.